Compare GSK plc (GSK) vs Rocket Lab USA Inc (RKLB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs Rocket Lab USA Inc — how do they compare? GSK plc trades at $52.73 (market cap $101.34B), while Rocket Lab USA Inc trades at $68.24 (market cap $47.61B). The key difference: GSK plc is far larger — about 2.1× Rocket Lab USA Inc's market cap, and GSK plc pays a 3.49% dividend while Rocket Lab USA Inc pays none. Which is the better fit depends on your goals.
| GSK | RKLB | |
|---|---|---|
Market Cap | $101.34B | $47.61B |
Sector | Health | Technology |
52-Week High | $61.18 | $150.23 |
52-Week Low | $36.20 | $39.48 |
Enterprise Value | $121.95B | $46.37B |
Dividend Yield | 3.49% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About Rocket Lab USA Inc
Rocket Lab USA, Inc. is an aerospace manufacturer and small-satellite launch service provider. The company specializes in developing rockets for orbital launch, including its flagship *Electron* vehicle, and is developing the next-generation, reusable *Neutron* rocket. Beyond launch services, Rocket Lab also offers satellite design, manufacturing, and spacecraft component solutions, positioning itself as an end-to-end provider for the space industry.
Read more on RKLB →
